Testing Lansoprazole on Human Gut Microbiota using a Gastroesophageal Reflux Model In Vitro
DOI:
https://doi.org/10.47611/jsrhs.v12i4.5557Keywords:
Lansoprazole, Human Gut Microbiota, Gastroesophageal Reflux, In Vitro, E.coli, S.epidermidis, Proton Pump InhibitorAbstract
One in five Americans experience Gastroesophageal Reflux Disease, but the disease has multiple treatments, such as Proton Pump Inhibitors (PPI). However, the effects of PPIs may induce more harmful effects on the gut microbiome, and less treatable symptoms such as inflammatory bowel disease, diabetes, obesity, and even cancer may occur. PPIs reduce acid secretion within the stomach and reduce stomach acid in the esophagus. The side effects of PPIs on the gut microbiome have yet to be researched extensively. This study suggests that Lansoprazole, a PPI, may cause significant changes in gut bacteria growth. An adapted method of in vitro digestion modeled the digestive systems of a human. Solutions replicating the environment of the mouth, stomach, and intestines were combined with a human dosage of Lansoprazole, and the pH was adjusted at different segments to model the low pH environments of the stomach and the neutral pH of the intestines. The respective solutions were then exposed to gut bacteria, E. coli, and S. epidermidis. These gut bacterias represent specific bacteria species within the intestinal tract. Data indicated that E. coli grew approximately 50% as much as the control at 20-minutes and less than 25% as much as the control at 40-minutes. S. epidermidis grew significantly less than the control, with approximately 60% as much at 20-minutes and approximately 15% as much at 40-minutes. In conclusion, studies indicate Lansoprazole treats GERD, but side effects from consuming the drug may cause gut dysbiosis, which may lead to the side effects previously mentioned.
Downloads
References or Bibliography
Afzaal, M., Saeed, F., Shah, Y. A., Hussain, M., Rabail, R., Socol, C. T., Hassoun, A., Pateiro, M., Lorenzo, J. M., Rusu, A. V., & Aadil, R. M. (2022). Human gut microbiota in health and disease: Unveiling the relationship. Frontiers in Microbiology, 13. https://doi.org/10.3389/fmicb.2022.999001
Akinkunmi, E. O., Adeyemi, O. I., Igbeneghu, O. A., Olaniyan, E. O., Omonisi, A. E., & Lamikanra, A. (2014). The pathogenicity of staphylococcus epidermidis on the intestinal organs of rats and mice: An experimental investigation. BMC Gastroenterology, 14(1). https://doi.org/10.1186/1471-230X-14-126
Ben-Joseph, E. P. (2022). E. Coli Infections: Diarrhea (for Teens) - Nemours KidsHealth. Kids Health. https://kidshealth.org/en/teens/e-coli.html
Biagini, F., Calvigioni, M., Lapomarda, A., Vecchione, A., Magliaro, C., De maria, C., Montemurro, F., Celandroni, F., Mazzantini, D., Mattioli-belmonte, M., Ghelardi, E., & Vozzi, G. (2020). A novel 3D in vitro model of the human gut microbiota. Scientific Reports, 10(1). https://doi.org/10.1038/s41598-020-78591-w
Boulton, K. H. A., Fisher, J., Woodcock, A. D., & Dettmar, P. W. (2021). Pepsin as a biomarker for self-diagnosing reflux associated symptoms in UK and USA individuals. Annals of Esophagus. http://dx.doi.org/10.21037/aoe-20-7
Brodkorb, A., Egger, L., Alminger, M., Alvito, P., Assunção, R., Ballance, S., Bohn, T., Bourlieu-lacanal, C., Boutrou, R., Carrière, F., Clemente, A., Corredig, M., Dupont, D., Dufour, C., Edwards, C., Golding, M., Karakaya, S., Kirkhus, B., Le feunteun, S., . . . Santos, C. N. (2019). INFOGEST static in vitro simulation of gastrointestinal food digestion. Nature Protocols, 14(4), 991-1014. https://doi.org/10.1038/s41596-018-0119-1
Bruno, G., Zaccari, P., Rocco, G., Scalese, G., Panetta, C., Porowska, B., Pontone, S., & Severi, C. (2019). Proton pump inhibitors and dysbiosis: Current knowledge and aspects to be clarified. World Journal of Gastroenterology, 25(22), 2706-2719. https://doi.org/10.3748/wjg.v25.i22.2706
Clarrett, D. M., & Hachem, C. (2018). Gastroesophageal Reflux Disease (GERD).
Missouri medicine, 115(3), 214–218.
Critical Care, 9(1). (2004). https://doi.org/10.1186/cc2980
Cunha, J. P. (2021, August 25). Lansoprazole: Generic, Uses, Side Effects, Dosages, Interactions, Warnings. RxList. https://www.rxlist.com/consumer_lansoprazole_prevacid/drugs-condition.htm
Degruttola, A. K., Low, D., Mizoguchi, A., & Mizoguchi, E. (2016). Current understanding of dysbiosis in disease in human and animal models. Inflammatory Bowel Diseases, 22(5), 1137-1150. https://doi.org/10.1097/MIB.0000000000000750
Ericsson, A. C., & Franklin, C. L. (2021). The gut microbiome of laboratory mice: Considerations and best practices for translational research. Mammalian Genome, 32(4), 239-250. https://doi.org/10.1007/s00335-021-09863-7
Fakhoury, M., Al-salami, H., Negrulj, R., & Mooranian, A. (2014). Inflammatory bowel disease: Clinical aspects and treatments. Journal of Inflammation Research, 113. https://doi.org/10.2147/JIR.S65979
Ferrer, M., Chernikova, T. N., Yakimov, M. M., Golyshin, P. N., & Timmis, K. N. (2003). Chaperonins govern growth of escherichia coli at low temperatures. Nature Biotechnology, 21(11), 1267. https://doi.org/10.1038/nbt1103-1266b
Fisher, J., Mclaughlin, F., Fawkes, N., Tipple, H., Coyle, C., & Dettmar, P. W. (2021). A novel in vitro model for determining the optimum pH and dose volume of new liquid alginate for infant reflux suppression. Drugs in R&D, 21(3), 331-339. https://doi.org/10.1007/s40268-021-00356-1
Galmiche, J. P., Bruley des varannes, S., Ducrotté, P., Sacher-huvelin, S., Vavasseur, F., Taccoen, A., Fiorentini, P., & Homerin, M. (2004). Tenatoprazole, a novel proton pump inhibitor with a prolonged plasma half-life: Effects on intragastric pH and comparison with esomeprazole in healthy volunteers. Alimentary Pharmacology & Therapeutics, 19(6), 655-662. https://doi.org/10.1111/j.1365-2036.2004.01893.x
Gastroesophageal Reflux Disease Treatments. (2017, March 10). Gastro Health. Retrieved March 6, 2023, from https://gastrohealth.com/news/patient-care/gastroesophageal-reflux-disease-a-clinical-discussion
Gibson, P. R., Anderson, R. P., Mariadason, J. M., & Wilson, A. J. (1996). Protective role of the epithelium of the small intestine and colon. Inflammatory Bowel Diseases, 2(4), 279-302. https://doi.org/10.1002/ibd.3780020412
Harada, M., Kuda, T., Nakamura, S., Lee, G., Takahashi, H., & Kimura, B. (2021). In vitro antioxidant and immunomodulation capacities of low-molecular weight-alginate- and laminaran-responsible gut indigenous bacteria. LWT, 151, 112127. https://doi.org/10.1016/j.lwt.2021.112127
Hashimoto, T., Koga, M., & Masaoka, Y. (2009). Advantages of a diluted nutrient broth medium for isolating n2-producing denitrifying bacteria of α-Proteobacteria in surface and subsurface upland soils. Soil Science and Plant Nutrition, 55(5), 647-659. https://doi.org/10.1111/j.1747-0765.2009.00404.x
Heda, R., & Toro, F. (2022, January). Tombazzi CR. Physiology, Pepsin. https://www.ncbi.nlm.nih.gov/books/NBK537005/
Imhann, F., Bonder, M. J., Vich vila, A., Fu, J., Mujagic, Z., Vork, L., Tigchelaar, E. F., Jankipersadsing, S. A., Cenit, M. C., Harmsen, H. J. M., Dijkstra, G., Franke, L., Xavier, R. J., Jonkers, D., Wijmenga, C., Weersma, R. K., & Zhernakova, A. (2015). Proton pump inhibitors affect the gut microbiome. Gut, 65(5), 740-748. https://doi.org/10.1136/gutjnl-2015-310376
Inman, M. (2011). How bacteria turn fiber into food. PLoS Biology, 9(12), e1001227. https://doi.org/10.1371/journal.pbio.1001227
Javed, M., Ali, M. H., Tanveer, M. S., & Tanveer, M. H. (2020). Omeprazole vs lansoprazole in the management of gastroesophageal reflux disease: A systematic literature review. Journal of Medical Research and Innovation, 4(2), e000204. https://doi.org/10.32892/jmri.204
Johns Hopkins Medicine. (n.d.). The Digestive Process: What Is the Role of Your Pancreas in Digestion?., from https://www.hopkinsmedicine.org/health/conditions-and-diseases/the-digestive-process-what-is-the-role-of-your-pancreas-in-digestion
Katouli M. (2010). Population structure of gut Escherichia coli and its role in development of
extra-intestinal infections. Iranian journal of microbiology, 2(2), 59–72.
Kinoshita, Y., Ishimura, N., & Ishihara, S. (2018). Advantages and disadvantages of long-term proton pump inhibitor use. Journal of Neurogastroenterology and Motility, 24(2), 182-196. https://doi.org/10.5056/jnm18001
Langtry, H. D., & Wilde, M. I. (1997). Lansoprazole. Drugs, 54(3), 473-500. https://doi.org/10.2165/00003495-199754030-00010
Lee, E. H., Cha, K. H., Vuong, T. T., Kim, S. M., & Pan, C.-H. (2018). Comparison of static and dynamic in vitro digestion models to estimate the bioaccessibility of lutein in lutein-rich foods. Applied Biological Chemistry, 61(4), 441-447. https://doi.org/10.1007/s13765-018-0378-0
Lim, J. Y., Yoon, J., & Hovde, C. J. (2010). A brief overview of Escherichia coli O157:H7 and
its plasmid O157. Journal of microbiology and biotechnology, 20(1), 5–14.
Liofilchem®. (2017, 9 12). Nutrient Broth. https://www.humeau.com/media/blfa_files/TC_Nutrient-bouillon_EN_280618.pdf
Maldonado, A. (2021, January 25). A healthy microbiome builds a strong immune system that could help defeat COVID-19. UMass Medical School. https://www.umassmed.edu/news/news-archives/2021/01/a-healthy-microbiome-builds-a-strong-immune-system-that-could-help-defeat-covid-19/
Maradey-romero, C., & Fass, R. (2014). New and future drug development for gastroesophageal reflux disease. Journal of Neurogastroenterology and Motility, 20(1), 6-16. https://doi.org/10.5056/jnm.2014.20.1.6
Mayo Clinic. (2023, February 1). Lansoprazole (Oral Route) Proper Use. IBM Micromedex., From https://www.mayoclinic.org/drugs-supplements/lansoprazole-oral-route/proper-use/drg-20067214
Meloni, M., Buratti, P., Carriero, F., & Ceriotti, L. (2021). In vitro modeling of barrier impairment associated with gastro-oesophageal reflux disease (GERD). Clinical and Experimental Gastroenterology, Volume 14, 361-373. https://doi.org/10.2147/CEG.S325346
Meng, C., Bai, C., Brown, T. D., Hood, L. E., & Tian, Q. (2018). Human gut microbiota and gastrointestinal cancer. Genomics, Proteomics & Bioinformatics, 16(1), 33-49. https://doi.org/10.1016/j.gpb.2017.06.002
Metz, D. C., Pisegna, J. R., Ringham, G. L., Feigenbaum, K., Koviack, P. D.,Maton, P. N., Gardner, J. D., & Jensen, R. T. (1993). Prospective study of efficacy and safety of lansoprazole in zollinger-ellison syndrome. Digestive Diseases and Sciences, 38(2), 245-256. https://doi.org/10.1007/BF01307541
The Microbial World. (n.d.). The cell wall surrounds and holds in the microbe. https://bionumbers.hms.harvard.edu/bionumber.aspx?s=n&v=2&id=111941
Minalyan, A., Gabrielyan, L., Scott, D., Jacobs, J., & Pisegna, J. R. (2017). The gastric and intestinal microbiome: Role of proton pump inhibitors. Current Gastroenterology Reports, 19(8). https://doi.org/10.1007/s11894-017-0577-6
Minekus, M., Alminger, M., Alvito, P., Ballance, S., Bohn, T., Bourlieu, C., Carrière, F., Boutrou, R., Corredig, M., Dupont, D., Dufour, C., Egger, L., Golding, M., Karakaya, S., Kirkhus, B., Le feunteun, S., Lesmes, U., Macierzanka, A., Mackie, A., . . . Brodkorb, A. (2014). A standardized staticin vitrodigestion method suitable for food – an international consensus. Food Funct., 5(6), 1113-1124. https://doi.org/10.1039/C3FO60702J
Mitchell, E. (n.d.). Gram Positive vs Gram Negative Bacteria and the Fight Against HAIs. Health. Care. | An Educational Blog. Retrieved March 6, 2023, from https://blog.eoscu.com/blog/gram-positive-vs-gram-positive
Namvar, A. E., Bastarahang, S., Abbasi, N., Ghehi, G. S., Farhadbakhtiarian, S., Arezi, P., Hosseini, M., Baravati, S. Z., Jokar, Z., & Chermahin, S. G. (2014). Clinical characteristics of staphylococcus epidermidis: A systematic review. GMS Hygiene and Infection Control; 9(3):Doc23; ISSN 2196-5226. https://doi.org/10.3205/dgkh000243
Nardone, G., & Compare, D. (2015). The human gastric microbiota: Is it time to rethink the pathogenesis of stomach diseases? United European Gastroenterology Journal, 3(3), 255-260. https://doi.org/10.1177/2050640614566846
National Cancer Institute. (n.d.). Definition of small intestine - NCI Dictionary of Cancer Terms - NCI.. https://www.cancer.gov/publications/dictionaries/cancer-terms/def/small-intestine
Nguyen, T. L. A., Vieira-silva, S., Liston, A., & Raes, J. (2015). How informative is the mouse for human gut microbiota research? Disease Models & Mechanisms, 8(1), 1-16. https://doi.org/10.1242/dmm.017400
Nu-ri, I., Kim, B., Jung, K.-Y., Kim, T. H., & Baek, S.-K. (2021). Non-Surgical animal model of gastroesophageal reflux disease by overeating induced in mice. Journal of Investigative Medicine, 69(6), 1208-1214. https://doi.org/10.1136/jim-2020-001691
Petri, W. A., Miller, M., Binder, H. J., Levine, M. M., Dillingham, R., & Guerrant, R. L. (2008). Enteric infections, diarrhea, and their impact on function and development. Journal of Clinical Investigation, 118(4), 1277-1290. https://doi.org/10.1172/JCI34005
Rosen RD, Winters R. Physiology, Lower Esophageal Sphincter. [Updated 2022 Apr 5]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2022 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK557452
Shin, J. M., Munson, K., Vagin, O., & Sachs, G. (2008). The gastric hk-atpase: Structure, function, and inhibition. Pflügers Archiv - European Journal of Physiology, 457(3), 609-622. https://doi.org/10.1007/s00424-008-0495-4
Sinha, S. (2023, February 20). Lansoprazole: Uses, Dosage, Side Effects. Drugs.com., from https://www.drugs.com/lansoprazole.html
Thrift, A. P., Kramer, J. R., Qureshi, Z., Richardson, P. A., & El-serag, H. B. (2013). Age at onset of GERD symptoms predicts risk of barrett's esophagus. American Journal of Gastroenterology, 108(6), 915-922. https://doi.org/10.1038/ajg.2013.72
Tutuian, R., & Castell, D. O. (2006). Gastroesophageal reflux monitoring: pH and impedance. GI Motility online. https://doi.org/10.1038/gimo31
Valdes, A. M., Walter, J., Segal, E., & Spector, T. D. (2018). Role of the gut microbiota in nutrition and health. BMJ, k2179. https://doi.org/10.1136/bmj.k2179
Vasavada, N. (n.d.). ANOVA with post-hoc Tukey HSD Test Calculator with Scheffé, Bonferroni and Holm multiple comparison - input k, the number of treatments. Online Web Statistical Calculators. https://astatsa.com/OneWay_Anova_with_TukeyHSD/
Vitale, C., Ma, T. M., Sim, J., Altheim, C., Martinez-nieves, E., Kadiyala, U., Solomon, M. J., & Vanepps, J. S. (2021). Staphylococcus epidermidis has growth phase dependent affinity for fibrinogen and resulting fibrin clot elasticity. Frontiers in Microbiology, 12. https://doi.org/10.3389/fmicb.2021.649534
Wang, J., Lang, T., Shen, J., Dai, J., Tian, L., & Wang, X. (2019). Core gut bacteria analysis of healthy mice. Frontiers in Microbiology, 10. https://doi.org/10.3389/fmicb.2019.00887
Wei, L., Singh, R., Ro, S., & Ghoshal, U. C. (2021). Gut microbiota dysbiosis in functional gastrointestinal disorders: Underpinning the symptoms and pathophysiology. JGH Open, 5(9), 976-987. https://doi.org/10.1002/jgh3.12528
Published
How to Cite
Issue
Section
Copyright (c) 2023 Taj Chunawala; Cathy Messenger
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Copyright holder(s) granted JSR a perpetual, non-exclusive license to distriute & display this article.
